Loading...
XASXHMD
Market cap10mUSD
Dec 23, Last price  
0.02AUD
1D
4.76%
1Q
0.00%
IPO
-88.42%
Name

Hera Med Ltd

Chart & Performance

D1W1MN
XASX:HMD chart
P/E
P/S
26.86
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
24.37%
Rev. gr., 5y
39.17%
Revenues
403k
+27.58%
0077,169209,21057,399115,450315,789402,897
Net income
-5m
L-36.04%
-2,853,119-1,028,027-3,766,480-4,502,374-4,879,144-7,606,118-7,040,452-4,502,770
CFO
0k
P
-1,924,947-713,617-1,766,146-3,923,879-4,036,985-4,305,764-3,693,3020
Earnings
May 30, 2025

Profile

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a digital pregnancy monitor platform for the creation and implementation of digital health solutions for maternity care management. It also develops EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.
IPO date
Dec 12, 2018
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
403
27.58%
316
173.53%
115
101.14%
Cost of revenue
4,394
3,929
4,079
Unusual Expense (Income)
NOPBT
(3,991)
(3,613)
(3,963)
NOPBT Margin
Operating Taxes
5
125
Tax Rate
NOPAT
(3,991)
(3,613)
(4,089)
Net income
(4,503)
-36.04%
(7,040)
-7.44%
(7,606)
55.89%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,121
3,811
4,256
BB yield
-33.93%
-13.93%
-9.94%
Debt
Debt current
209
263
4,701
Long-term debt
32
Deferred revenue
Other long-term liabilities
354
505
549
Net debt
(482)
(3,596)
(194)
Cash flow
Cash from operating activities
(3,693)
(4,306)
CAPEX
(996)
(114)
Cash from investing activities
(996)
(114)
Cash from financing activities
2,020
3,662
6,506
FCF
(3,916)
(3,684)
(4,100)
Balance
Cash
723
3,858
4,895
Long term investments
Excess cash
703
3,843
4,889
Stockholders' equity
(8,857)
4,220
(146)
Invested Capital
10,053
1,384
5,457
ROIC
ROCE
EV
Common stock shares outstanding
260,462
218,862
178,499
Price
0.02
-80.80%
0.13
-47.92%
0.24
118.18%
Market cap
6,251
-77.15%
27,358
-36.14%
42,840
202.93%
EV
5,769
23,762
42,646
EBITDA
(3,991)
(3,096)
(3,601)
EV/EBITDA
Interest
90
2,507
2,230
Interest/NOPBT